These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 21918979)

  • 1. Serum MMP-8 levels increase in colorectal cancer and correlate with disease course and inflammatory properties of primary tumors.
    Väyrynen JP; Vornanen J; Tervahartiala T; Sorsa T; Bloigu R; Salo T; Tuomisto A; Mäkinen MJ
    Int J Cancer; 2012 Aug; 131(4):E463-74. PubMed ID: 21918979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High Expression of MMP-9 in Primary Tumors and High Preoperative MPO in Serum Predict Improved Prognosis in Colorectal Cancer with Operable Liver Metastases.
    Peltonen R; Hagström J; Tervahartiala T; Sorsa T; Haglund C; Isoniemi H
    Oncology; 2021; 99(3):144-160. PubMed ID: 33027796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-serum MMP-8 levels are associated with decreased survival and systemic inflammation in colorectal cancer.
    Sirniö P; Tuomisto A; Tervahartiala T; Sorsa T; Klintrup K; Karhu T; Herzig KH; Mäkelä J; Karttunen TJ; Salo T; Mäkinen MJ; Väyrynen JP
    Br J Cancer; 2018 Jul; 119(2):213-219. PubMed ID: 29808017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum matrix metalloproteinase 7 levels identifies poor prognosis advanced colorectal cancer patients.
    Maurel J; Nadal C; Garcia-Albeniz X; Gallego R; Carcereny E; Almendro V; Mármol M; Gallardo E; Maria Augé J; Longarón R; Martínez-Fernandez A; Molina R; Castells A; Gascón P
    Int J Cancer; 2007 Sep; 121(5):1066-71. PubMed ID: 17487834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated MMP-8 and decreased myeloperoxidase concentrations associate significantly with the risk for peripheral atherosclerosis disease and abdominal aortic aneurysm.
    Pradhan-Palikhe P; Vikatmaa P; Lajunen T; Palikhe A; Lepäntalo M; Tervahartiala T; Salo T; Saikku P; Leinonen M; Pussinen PJ; Sorsa T
    Scand J Immunol; 2010 Aug; 72(2):150-7. PubMed ID: 20618774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum matrix-metalloproteinase-1 is a bona fide prognostic marker for colorectal cancer.
    Tahara K; Mimori K; Iinuma H; Iwatsuki M; Yokobori T; Ishii H; Anai H; Kitano S; Mori M
    Ann Surg Oncol; 2010 Dec; 17(12):3362-9. PubMed ID: 20617463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limited value of preoperative serum analyses of matrix metalloproteinases (MMP-2, MMP-9) and tissue inhibitors of matrix metalloproteinases (TIMP-1, TIMP-2) in colorectal cancer.
    Oberg A; Höyhtyä M; Tavelin B; Stenling R; Lindmark G
    Anticancer Res; 2000; 20(2B):1085-91. PubMed ID: 10810401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma matrix metalloproteinase-9 level is better than serum matrix metalloproteinase-9 level to predict gastric cancer evolution.
    Wu CY; Wu MS; Chiang EP; Chen YJ; Chen CJ; Chi NH; Shih YT; Chen GH; Lin JT
    Clin Cancer Res; 2007 Apr; 13(7):2054-60. PubMed ID: 17404086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum MMPs 7-9 and their inhibitors during glucocorticoid and anti-TNF-α therapy in pediatric inflammatory bowel disease.
    Mäkitalo L; Rintamäki H; Tervahartiala T; Sorsa T; Kolho KL
    Scand J Gastroenterol; 2012 Jul; 47(7):785-94. PubMed ID: 22519363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of plasma MMP-2 and MMP-9 levels as a surrogate for tumour expression in colorectal cancer patients.
    Tutton MG; George ML; Eccles SA; Burton S; Swift RI; Abulafi AM
    Int J Cancer; 2003 Nov; 107(4):541-50. PubMed ID: 14520690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative estimation of matrix metalloproteinases 2 and 7 (MMP-2, MMP-7) and tissue inhibitors of matrix metalloproteinases 1 and 2 (TIMP-1, TIMP-2) in colorectal carcinoma tissue samples.
    Pesta M; Holubec L; Topolcan O; Cerna M; Rupert K; Holubec LS; Treska V; Kormunda S; Elgrova L; Finek J; Cerny R
    Anticancer Res; 2005; 25(5):3387-91. PubMed ID: 16101153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High serum levels of matrix metalloproteinase-9 and matrix metalloproteinase-1 are associated with rapid progression in patients with metastatic melanoma.
    Nikkola J; Vihinen P; Vuoristo MS; Kellokumpu-Lehtinen P; Kähäri VM; Pyrhönen S
    Clin Cancer Res; 2005 Jul; 11(14):5158-66. PubMed ID: 16033831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The membrane-anchored matrix metalloproteinase (MMP) regulator RECK in combination with MMP-9 serves as an informative prognostic indicator for colorectal cancer.
    Takeuchi T; Hisanaga M; Nagao M; Ikeda N; Fujii H; Koyama F; Mukogawa T; Matsumoto H; Kondo S; Takahashi C; Noda M; Nakajima Y
    Clin Cancer Res; 2004 Aug; 10(16):5572-9. PubMed ID: 15328199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of ets-related transcriptional factor E1AF expression with tumour progression and overexpression of MMP-1 and matrilysin in human colorectal cancer.
    Horiuchi S; Yamamoto H; Min Y; Adachi Y; Itoh F; Imai K
    J Pathol; 2003 Aug; 200(5):568-76. PubMed ID: 12898592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix metalloproteinases 2 and 9 in situ mRNA expression in colorectal tumors from Iraqi patients.
    Ahmed MM; Mohammed SH
    Indian J Pathol Microbiol; 2011; 54(1):7-14. PubMed ID: 21393869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix metalloproteinases, their tissue inhibitors and colorectal cancer staging.
    Baker EA; Bergin FG; Leaper DJ
    Br J Surg; 2000 Sep; 87(9):1215-21. PubMed ID: 10971431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between expression of matrix metalloproteinase-2 (MMP-2), and matrix metalloproteinase-9 (MMP-9) and angiogenesis in colorectal adenocarcinoma.
    Kim TS; Kim YB
    J Korean Med Sci; 1999 Jun; 14(3):263-70. PubMed ID: 10402168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinase (MMP) -1, -2, -3 and -9 promoter polymorphisms in colorectal cancer.
    Elander N; Söderkvist P; Fransén K
    Anticancer Res; 2006; 26(1B):791-5. PubMed ID: 16739355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of type 2 diabetes and atorvastatin treatment on serum levels of MMP-7 and MMP-8.
    Kadoglou NP; Sailer N; Fotiadis G; Kapelouzou A; Liapis CD
    Exp Clin Endocrinol Diabetes; 2014 Jan; 122(1):44-9. PubMed ID: 24464597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of plasma MMP-8, MMP-9 and TIMP-1 identifies candidate cardiometabolic risk marker in metabolic syndrome: results from double-blinded nested case-control study.
    Hoseini SM; Kalantari A; Afarideh M; Noshad S; Behdadnia A; Nakhjavani M; Esteghamati A
    Metabolism; 2015 Apr; 64(4):527-38. PubMed ID: 25633268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.